Health Care/Hospital APAC News & Press Release Distribution

Health Care/Hospital

All
Global

CSL Vifor and Travere Therapeutics announce sparsentan receives positive CHMP opinion for the treatment of IgA nephropathy

Committee for Medicinal Products for Human Use (CHMP) recommends approval of the conditional marketing authorization (CMA) for sparsentan for the treatment of IgA nephropathy (IgAN) inEurope Positive CHMP opinion is based on pivotal phase-III PROTECT study results European Commission decision is...

2024-02-23 15:00 1457

CSL Vifor and Travere Therapeutics announce sparsentan receives positive CHMP opinion for the treatment of IgA nephropathy

Kakao Brain Debuts 'KARA-CXR', a Web-Based Radiology Report Service Powered by Large-Scale AI

"AI Assistant for Radiologists" * Kakao Brain introduced last month a web-based radiology report Research Use Only (RUO) service powered by its large-scale artificial intelligence (AI), "KARA-CXR." * Kakao Brain plans to expand the interactive functions supporting various imaging medical exa...

2024-02-22 21:00 1736

Telix 2023 Full Year Results: Inaugural Profit Achieved, Strong Revenue Growth Underpins Investment in Late-stage Pipeline

MELBOURNE, Australia, Feb. 22, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces its results for the financial year ended31 December 2023. All figures are in AUD$ unless otherwise stated.[1] 2023 highlights * Total Group revenue of $502.5M, an...

2024-02-22 17:31 2076

Pretty Beauty Group Teams Up with Renowned Korean Medical Device Brand TENTECH to Introduce Revolutionary "TEN HI Collagen Replication Gun" Beauty Technology

HONG KONG, Feb. 22, 2024 /PRNewswire/ -- Innovative Radiofrequency Technology for Youthful, Firm Skin Pretty Beauty has recently introduced the "TEN HI Collagen Replication Gun" developed and produced by the renowned Korean medical device manufacturer TENTECH. This is an innovative and safe bea...

2024-02-22 17:12 1513

Everest Medicines' Partner Pfizer Announces European Commission Approves VELSIPITY® for Patients with Moderately to Severely Active Ulcerative Colitis

--VELSIPITY is the first and only oral advanced ulcerative colitis therapy approved for use in patients 16 years of age or older in the EU-- SHANGHAI, Feb. 22, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company")'s partner Pfizer Inc. (NYSE: PFE) announced that the ...

2024-02-22 08:59 1566

Lanvin Group Resiliency was Key in 2023, Preliminary Revenues Up 1% Year-on-Year

* Revenue of €426 million for FY2023, a 1% increase over FY 2022 * Despite challenging conditions, Lanvin Group grew revenue by 8% in APAC * Resiliency through creative transition at Lanvin brand helped improve sales trend in the second half of 2023 * Positive signals in the DTC channel, in...

2024-02-21 18:00 2799

Astonishing brain tumour research wins the BIAL Award in Biomedicine 2023 worth 300,000 Euro

PORTO, Portugal, Feb. 21, 2024 /PRNewswire/ -- A team of researchers from Germany, the USA, the UK, and Norway won the third edition of the BIAL Award in Biomedicine , a300,000 Euro prize promoted by the BIAL Foundation

2024-02-21 16:00 1414

Astonishing brain tumour research wins the BIAL Award in Biomedicine 2023 worth 300,000 Euro

Findings of a Phase III Clinical Study of Sanbexin® Sublingual Tablets Published in JAMA

NANJING, China, Feb. 21, 2024 /PRNewswire/ -- On February 19, 2024, the Journal of American Medical Association•Neurology (JAMA NEUROLOGY, IF: 29.0) published online the key findings of a phase III clinical study (NCT04950920) (the "TASTE-SL Study") investigating Sanbexin® (a combination of edara...

2024-02-21 12:26 1878

Findings of a Phase III Clinical Study of Sanbexin® Sublingual Tablets Published in JAMA

Datasea Establishes Joint Venture Company to Further Penetrate the Estimated Approximately 527.8 billion US Dollars 5G Market in China

New Entity to be Focused on Increasing Scale of Datasea's 5G Services Utilizing Artificial Intelligence, which is Expected to Drive Significant Revenue in 2024 BEIJING, Feb. 20, 2024 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), aNevada incorporated digital technology ...

2024-02-21 01:31 1264

Bowtie Term CI Early Stage and Multiple Cover is rated top in the industry Examining its advantages from the product design perspective

HONG KONG, Feb. 20, 2024 /PRNewswire/ -- In December 2023, Bowtie launched a new Term Critical Illness Insurance product calledBowtie Term CI Early Stage and Multiple Cover . Shortly after it is launched, it was rated top by the independent...

2024-02-20 14:59 1338

MediThinQ Marks Milestone as First Asian Startup to Globally Launch XR Surgical Displays, Securing Key Partnerships and Multimillion-Dollar Investment

SINGAPORE, Feb. 20, 2024 /PRNewswire/ -- MediThinQ, a pioneering Korean startup specialising in extended reality (XR) wearable displays for surgery, is making waves as the first Asian startup to globally launch XR surgical displays. The company has successfully secured significant deals with indu...

2024-02-20 14:00 1391

MediThinQ Marks Milestone as First Asian Startup to Globally Launch XR Surgical Displays, Securing Key Partnerships and Multimillion-Dollar Investment

Mount Alvernia Hospital Elevates Holistic Healthcare with OutSystems

Using the low-code platform, the hospital's in-house developers saved half the time it typically takes to develop applications for staff, patients and visitors. SINGAPORE, Feb. 20, 2024 /PRNewswire/ -- Mount Alvernia Hospital has partnered with OutSystems, a global leader in high-performance low...

2024-02-20 14:00 1744

Mount Alvernia Hospital Elevates Holistic Healthcare with OutSystems

Ciracle Cosmeceutical Brand to Host " Pore Control Blackhead Off Sheet" Experience Influencer Recruitment Event

SEOUL, South Korea, Feb. 19, 2024 /PRNewswire/ -- Ciracle, a cosmeceutical brand dedicated to pursuing skin health, will be hosting an influencer recruitment eventto experience the "Pore Control Blackhead Off Sheet" and other Ciracle products on its SNS platforms starting aroundthis April.

2024-02-20 13:28 1313

Innovent Announces Primary Endpoint Met in the Phase 3 Clinical Trial (RESTORE-1) of IBI311 (Anti-IGF-1R Antibody) in Treating Thyroid Eye Disease and Plans to Submit NDA to the NMPA

ROCKVILLIE, MD. and SUZHOU, China, Feb. 20, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major di...

2024-02-20 08:22 2568

HKUST Neuroscientists Develop Highly Accurate Universal Diagnostic Blood Test for Alzheimer's Disease and Mild Cognitive Impairment

At a glance: * Remarkably high accuracy rate – over 96% for AD and 87% for MCI; * Applicable across diverse ethnic populations, including Chinese and European; * Enables early detection of AD and subsequent progression; * Captures multiple AD-associated biological pathways; * A game-chan...

2024-02-19 20:18 1658

SIBIONICS Announced to Exhibit at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

The company will be hosting an influencer meeting during the conference LOS ANGELES, Feb. 19, 2024 /PRNewswire/ -- SIBIONICS, the world's third-largest Continuous Glucose Monitoring (CGM) System brand, announced the company will be exhibiting at the International Fair of New Technologies in Diab...

2024-02-19 10:55 1630

SIBIONICS Announced to Exhibit at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

AffaMed Therapeutics Announces New Drug Application Acceptance by Singapore Health Sciences Authority (HSA) for DEXTENZA® for Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery, and Ocular Itching Associated with Allergic Conjunctivitis

SHANGHAI, Feb. 19, 2024 /PRNewswire/ -- AffaMed Therapeutics ("AffaMed"), a biotechnology company dedicated to developing and commercializing transformative pharmaceutical, and surgical products that address critical unmet medical needs in ophthalmology, today announced that the Singapore Health ...

2024-02-19 09:00 3079

Everest Medicines Announces Termination of Collaboration Agreements with Providence

-Everest will continue to develop self-discovered products utilizing the mRNA platform- SHANGHAI, Feb. 19, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative...

2024-02-19 08:20 1581

SwiftMR™, Game-Changing AI-Powered MRI Solution Gears Up in ANZ Market: AIRS Medical Forges Strategic Partnership with ParagonCare

SEOUL, South Korea, Feb. 19, 2024 /PRNewswire/ -- AIRS Medical Inc., a leading provider of AI-powered healthcare solutions, has announced a strategic partnership agreement with ParagonCare Limited(ASX: PGC), a premier provider of healthcare technology, devices, software, and consumables inAustral...

2024-02-19 06:00 1829

IFPA Releases an Innovative Psoriatic Care Roadmap and Action Playbook

STOCKHOLM, Feb. 16, 2024 /PRNewswire/ -- IFPA Forum Asia 2023, held in Singapore , brought together a diverse group of stakeholders, including patient advocates, their associations, family members, policymakers, healthcare professionals, and the private sector. Held inSingapore, the forum served a...

2024-02-16 17:00 2853

IFPA Releases an Innovative Psoriatic Care Roadmap and Action Playbook

1 ... 18 19 202122 23 24 ... 554